Capital World Investors Ab Cellera Biologics Inc. Call Options Transaction History
Capital World Investors
- $597 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABCL
# of Institutions
165Shares Held
110MCall Options Held
229KPut Options Held
200K-
Baker Bros. Advisors LP New York, NY27.5MShares$86.7 Million1.08% of portfolio
-
Baillie Gifford & CO12.9MShares$40.6 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$33.5 Million0.04% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.6MShares$14.5 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$14.3 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $898M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...